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to mania, with manic excitement and manic stupor 
dominating the initial presentation. 
Lithium and antipsychotic medication were 
commenced at the end of the ECT course and 
AR was discharged in a mildly hypomanic state. 
During follow-up, AR experienced one more manic 
episode and one depressive episode one and three 
years after the index admission: these confirmed 
the diagnosis of bipolar illness. 
The unusual feature of this case was the 
development of manic stupor. Although this 
condition is described in classical texts (e.g. 
Hamilton. 1974). in clinical practice most 
psychiatrists never see a case in their lifetime. It 
is seldom easy to make the diagnosis 
prospectively Usually, several differential 
diagnoses are entertained, including neuroleptic 
malignant syndrome, for such patients have often 
received neuroleptic drugs. The stupor ultimately 
resolves e-ther spontaneously or with the help of 
antipsychotic drugs, benzodiazepines, or ECT, 
and the diagnosis of manic stupor is 
restrospectively made once the stupor remits and 
the manic symptoms are uncovered. 
Descriptions of manic stupor are very rare, 
the most recent being those by Fink (1999); none 
have appeared in Indian literature. What is notable 
about the present case is that the stupor was 
prolonged (it lasted more than two days), and a 
theme of ecstasy, rather than delirious behaviour, 
predominated. 
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TREATING MANIC STUPOR 
To the editor, 
Dr. Chittaranjan Andrade brought his 
experience with a patient in "manic stupor" to my 
attention The letter has much to teach us, and is 
a welcome reminder that manic depressive illness 
takes many forms,some of which are life-
threatening. 
Similar acute excited states have been 
described as Bell's mania, manic delirium,delirious 
mania,catatonic excitement, and oneiroid state 
(among others)(Fink,1999). The excitement and 
insomnia are often so severe as to call for repeated 
parenteral administration of high potency 
antipsychotic drugs. When patients are 
dehydrated,such treatment often induces a 
neurotoxic state marked by rigidity,negativism,and 
mutism. When this state is accompanied by fever 
and autonomic instability, the syndrome is labelled 
"neuroleptic malignant syndrome", a type of 
malignant catatonia(Fink, 1996) 
The treatments that are prescribed vary with 
the therapist's views of the chemical pathology. 
When dopamine blockade is pictured as the 
cause of the illness, dopamine agonists and 
dantrolene are prescribed(Caroff S.N.et al., 1998). 
Alternatively, when trie illness is pictured as a form 
of catatonia, benzodiazepines and/or ECT are 
prescribed(Fink, 1997). Dr.Andrade sucessfully 
followed the second script,relieving both the 
patient's neurotoxic illness and the primary manic 
state with ECT. We favor the second route. We 
have had similar experiences to that described 
by Dr Andrade. 
!t excited manic patients, sedation with 
benzodiazepines and not with antipsychotic drugs 
is to be preferred A strong case for withholding 
antipsychotic drugs has been recently been made 
byTaylor(2001). 
Once the patient has developed a 
neurotoxic syndrome, antipsychotic drugs should 
no longer be administered. If the syndrome is not 
relieved by this simple expedient, accompanied 
by hydration and nursing care, ECT becomes the 
principal option(Philbrick,K.L.etal., 1994). In such 
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acute instances, relief can be hastened by 
applying ECT on three or four successive days, a 
course described as "ECT en bloc"(Stromgren, 
LS.,1997). 
ECT is also an effective anti-manic agent. 
It relieves not only the catatonic features, but the 
manic episode as well. For continuation treatment, 
antipsychotic medicines should be avoided. 
Continuation ECT is a safer effective option. Dr. 
Andrade's patient would probably have had a better 
clinical course with this continuation option. 
Considering the dramatic nature of manic 
excitement, it is surprising that so few examples 
are described in the literature. A goorily number 
of the patients are reported in descriptions of NMS. 
More than half the recorded cases of NMS are 
preceded by a manic phase, with the toxic 
syndrome precipitated by high doses of 
haloperidol. 
Dr. Andrade is to be congratulated in 
bringing this treatable, life-threatening condition 
to our attention. 
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CARDIOVASCULAR EFFECTS OF ECT 
Sir, 
Effects of ECT on the pulse rate, blood 
pressue (BP), and electrocardiogram (ECG) were 
studied in fifty six consecutive physically healthy 
psychiatric inpatients undergoing ECT for their 
psychiatric disability. The patients were included 
in the study with their consent. Patients with 
systemic or neurological illnesses, substance 
dependence, concurrent anticonvulsant drugs or 
ECT in the past six months were excluded. All 
patients underwent a thorough physical 
examination and routine hematological and 
biochemical investigations. VDRL, ECG, skull 
radiograph and fundus copy. Pre-anaesthetic 
check up was carried out by the anesthesiologist. 
All patients were given ECT in overnight 
fasting condition, modified with inj. atropine 1.2 
mg IV, inj. thiopentone 5 mg/kg body weight IV 
and inj. succinylchoiine 0.75 mg/kg body weight 
IV. Vigorous mask ventilation with ox/gen was 
begun during induction of anesthesia and 
continued until the patient could resume effective 
ventilation. The ECT device was an electronic 
sinewave model manufactured by Associate 
Electronic Engineers, Bangalore. ECT was 
administered using standard bitemporal electrode 
placement. The initial stimulus was 110 V for 0.6 
seconds. During each ECT voltage and duartion 
parameters were noted. Seizure duration was 
measured by the cuff method. Occurrence of 
seizure i.e. presence of convulsions in the cuffed 
arm for at least 30 seconds was required for an 
adequate seizure. Pulse rate, BP and ECG was 
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